| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.51 | 0.003 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |